Moderna
MRNA
#991
Rank
S$32.52 B
Marketcap
S$81.48
Share price
-0.03%
Change (1 day)
135.93%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: S$32.52 Billion

As of August 2026 Moderna has a market cap of S$32.52 Billion. This makes Moderna the world's 991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$32.52 B107.83%
2025S$15.65 B-25.43%
2024S$20.99 B-58.08%
2023S$50.07 B-45.87%
2022S$92.50 B-33.55%
2021S$139.21 B154.55%
2020S$54.69 B516.25%
2019S$8.87 B29.38%
2018S$6.85 B

End of Day market cap according to different sources

On Aug 13th, 2026 the market cap of Moderna was reported to be:

S$32.52 Billion
by Nasdaq info icon info icon
S$32.52 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$808.50 B 2,385.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$369.15 B 1,034.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$428.10 B 1,216.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S$0.72 B-97.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
S$3.81 B-88.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$1.06 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$38.90 B 19.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S$15.43 B-52.56%๐Ÿ‡บ๐Ÿ‡ธ USA